These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23142459)
1. Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography. O'Shaughnessy CM; Micoli F; Gavini M; Goodall M; Cobbold M; Saul A; Maclennan CA J Immunol Methods; 2013 Jan; 387(1-2):199-210. PubMed ID: 23142459 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella. Goh YS; Clare S; Micoli F; Saul A; Mastroeni P; MacLennan CA Infect Immun; 2015 Sep; 83(9):3722-31. PubMed ID: 26169269 [TBL] [Abstract][Full Text] [Related]
13. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines. Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974 [TBL] [Abstract][Full Text] [Related]
14. The Role of Maternally Acquired Antibody in Providing Protective Immunity Against Nontyphoidal Salmonella in Urban Vietnamese Infants: A Birth Cohort Study. de Alwis R; Tu LTP; Quynh NLT; Thompson CN; Anders KL; Van Thuy NT; Hieu NT; Vi LL; Chau NVV; Duong VT; Chau TTH; Tuyen HT; Nga TVT; Minh PV; Tan TV; Thu TNH; Nhu TDH; Thwaites GE; Simmons C; Baker S J Infect Dis; 2019 Jan; 219(2):295-304. PubMed ID: 30321351 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Salmonella Typhimurium core oligosaccharide and its reducing end 3-deoxy-d-manno-oct-2-ulosonic acid used for conjugate vaccine production. De Benedetto G; Micoli F; Londero S; Salvini L; Sturiale L; Garozzo D; Ravenscroft N; Giannelli C; Cescutti P Carbohydr Res; 2019 Jul; 481():43-51. PubMed ID: 31228656 [TBL] [Abstract][Full Text] [Related]
16. The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC. Marshall JM; Gunn JS Infect Immun; 2015 Oct; 83(10):3946-59. PubMed ID: 26195553 [TBL] [Abstract][Full Text] [Related]
17. Determination of O:4 antigen-antibody affinity level in O:5 antigen positive and negative variants of Salmonella enterica serovar Typhimurium. Nakai Y; Ito A; Ogawa Y; Aribam SD; Elsheimer-Matulova M; Shiraiwa K; Kisaka SMB; Hikono H; Nishikawa S; Akiba M; Kawahara K; Shimoji Y; Eguchi M FEMS Microbiol Lett; 2017 Apr; 364(7):. PubMed ID: 28369258 [TBL] [Abstract][Full Text] [Related]
18. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa. Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624 [TBL] [Abstract][Full Text] [Related]
20. Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States. Trebicka E; Jacob S; Pirzai W; Hurley BP; Cherayil BJ Clin Vaccine Immunol; 2013 Oct; 20(10):1491-8. PubMed ID: 23803904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]